Total Pain Relief for the Way You Live

OUR MISSION

Relief Technology’s  mission is to make available to the public life-improving pain mitigation and elimination technologies that until now were considered too leading edge to be considered mainstream  therapies.  Through the process of scientifically demonstrating their mechanisms of efficacy, Relief Technology has demonstrated this new technology to effective, safe, and beneficial to those in pain.  All of the Company’s planned medical devices and treatments are non-invasive and therefore will not need FDA approval.  The FDA has informed the Company that for non-invasive therapy devices or systems, Relief Technology only need to comply with the cleanliness and sterility portions (Title 21 – Subchapter H – Medical Devices - Part 800) of the regulations when used in a Practitioner’s environment. As each new devices is developed, the Company will file a USFDA 510K form seeking certification as a medial appliance for use in treatment as well as therapy environments.

Relief Technology has been pursuing and developing non-invasive technologies that act as a catalyst in helping the body’s natural healing powers over the past three years.  The Company has been working with two technologies that show great promises as non-invasive treatments for certain persistent and degenerative ailments and conditions. These two technologies include Pulse Electro-Magnetics (PEM) and Low Laser Light (LLL). Due to the Company’s exploration in the therapeutic benefits of these two technologies, Relief Technology has developed unique technologies in products that address Persistent Pain Management and Pain Mitigation.

Pulse Electro-Magnetics Therapy (PEMT) is a seventy-year-old proven application used to increase and enhance blood flow in the tissues of mammals. Until recently, companies did not know how to correctly produce magnetic pulses to have the desired effect of rejuvenating and stimulating tissue on a microscopic scale.  Relief Technology has developed a unique patent pending PEMT technology, DynaPulse^®[1], that reduces inflammation, the most direct cause of pain in the body, on the cellular level. The Company’s DynaPulse^® technology also invigorates cell regeneration and thereby diminishes the effects of aging on the tissue.  While there are numerous uses for PEMT, including bone regeneration, wound recovery, and scar reduction, Management has identified that largest most assailable market for Relief Technology’s patented technology in the alleviation, mitigation, and management of pain, a $32 billion per year market.

Low Level Laser Therapy (LLLT) or Photomedicine is a relatively new technology that has been shown to provide another non-invasive treatment for a variety of ailments and conditions.   Under Relief Technology’s application, this LLLT technology allows the body to absorb this external photonic energy on a cellular level and transform the light energy into chemical energy.  Relief Technology’s been able to develop technology that can stimulate tissue repair and regeneration that adds to anti-inflammatory effectiveness. This in turns allows the body to naturally accelerate the normal healing rate of tissue for a wide range of ailments.

While these treatments seem like something right out of Star Trek^®[2], Relief Technology is not the first company to deploy these technologies.  Numerous companies and individuals have already developed a market demand for this non-invasive technology.  Unfortunately, since these companies do not understand the physics behind these technologies, they are only able to observe the secondary benefits and not articulate the mechanisms that make them effective. Relief Technology is the first company to actually understand the physiological and biochemical response from using these technologies and with the Company’s patent pending utilizations, can now extend the effectiveness of each technology in Relief Technology’s target markets.